Ken Griffin Immucell Corp Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.18 - $5.48 $99,258 - $130,128
23,746 New
23,746 $115,000
Q3 2023

Nov 14, 2023
BUY
$4.53 - $5.61 $17,241 - $21,351
3,806 Added 33.94%
15,019 $80,000
Q2 2023

Aug 14, 2023
SELL
$4.64 - $5.98 $26,675 - $34,379
-5,749 Reduced 33.89%
11,213 $56,000
Q1 2023

May 15, 2023
BUY
$4.85 - $7.84 $82,265 - $132,982
16,962 New
16,962 $87,000

Others Institutions Holding ICCC

# of Institutions
23
Shares Held
1.15M
Call Options Held
0
Put Options Held
0
View Full List

About IMMUCELL CORP

ICCC Quotes by TradingView
  • Ticker ICCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,746,860
  • Market Cap $30.2M
  • Description
  • ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...
More about ICCC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email